The CIMP can lead to the silencing of tumour‐suppressor genes and loss of protein expression or overlap with the CIN pathway through TP53 mutation and Wnt or TGFβ signalling pathway activations.1, 6, 7. This evidence concerns the gene TGFB1 and cervical squamous intraepithelial neoplasia.